ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

May 7, 2004

Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices

February 7, 1997

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

May 31, 2013

NCI Cooperative Group, Cancer Center Trials Listed

February 27, 2009